Atypical antipsychotic-induced mania/hypomania: A review of recent case reports and clinical studies

International Journal of Psychiatry in Clinical Practice

Volumn 16, Issue 1, 2012, Pages 2-7

  Benyamina, Amine ^a   Samalin, Ludovic ^b  

^a Universite Paris Sud   (France)

^b UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

Author keywords

Atypical antipsychotics; Hypomania; Induced mania; Mania

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; FLUOXETINE; FLUPENTIXOL; OLANZAPINE; PALIPERIDONE; PAROXETINE; PEROSPIRONE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE; ZOTEPINE;

BIPOLAR DEPRESSION; BIPOLAR DISORDER; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; HUMAN; HYPOMANIA; MANIA; MOOD DISORDER; PRIORITY JOURNAL; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CLINICAL TRIALS AS TOPIC; DATABASES, BIBLIOGRAPHIC; HUMANS; MOOD DISORDERS; PLACEBOS; PREVALENCE; PSYCHOTIC DISORDERS; SCHIZOPHRENIA;

EID: 84856882080     PISSN: 13651501     EISSN: 14711788     Source Type: Journal    
DOI: 10.3109/13651501.2011.605957     Document Type: Review

References (40)

1. Aubry JM, Simon AE, Bertschy G. Possible induction of mania and hypomania by olanzapine or risperidone: a critical review of reported cases. J Clin Psychiatry 2000;61:649-55.
2. Rachid F, Bertschy G, BondolfiG, Aubry JM. Possible induction of mania or hypomania by atypical antipsychotics: an updated review of reported cases. J Clin Psychiatry 2004;65:1537-45.
3. Michalopoulou PG, Lykouras L. Manic/hypomanic symptoms induced by atypical antipsychotics: A review of the reported cases. Progress Neuro-Psychopharmacol Biol Psychiatry 2006;30:549-64. (Pubitemid 44389413)
4. Brugue E, Vieta E. Atypical antipsychotics in bipolar depression: Neurobiological basis and clinical implications. Progress Neuro-Psychopharmacol Biol Psychiatry 2007;31(1):275-82. (Pubitemid 44959242)
5. Vieta E, Calabrese JR, Goikolea JM, Raines S, Macfadden W, for the BSG. Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study. Bipolar Disord 2007;9(4):413-25. (Pubitemid 46865372)
6. Thase ME, Macfadden W, Weisler RH CW, Paulsson B, Khan A, Calabrese JR; BOLDER II Study Group. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study). J Clin Psychopharmacol 2006;26:600-9. (Pubitemid 44772737)
7. Calabrese JR, Keck PE Jr, Macfadden W, Minkwitz M, Ketter TA, Weisler RH, et al. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry 2005;162:1351-60. (Pubitemid 40905587)
8. Keck PEJ, Corya SA, Altshuler LL, Ketter TA MS, Case M, Briggs SD, Tohen M. Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depression. J Clin Psychiatry 2005;66:611-6. (Pubitemid 40733704)
9. Shelton RC, Stahl SM. Risperidone and paroxetine given singly and in combination for bipolar depression. J Clin Psychiatry 2004;65:1715-9.
10. Aggarwal A, Jain M, Khandelwal A, Jiloha RC. Amisulpride induced mania. Indian J Pharmacol 2010;42:112-3.
11. Akdemir A, Türkçapar H, Örsel S. Mania and hypomania with olanzapine use. Eur Psychiatry 2004;19:175-6. (Pubitemid 38670459)
12. Bakhla AK, Goyal N, Nizamie SH. Amisulpride-induced mania with interictal psychosis. Progress Neuro-Psychophar-macol Biol Psychiatry 2009;33:1572-3.
13. Baldaçara L, de Castro Ferrari MC, Monteiro BF, Uchida RR, Sanches M. Hypomania induced by atypical antipsy-chotics among schizophrenic patients: report of three cases. Pharmacopsychiatry 2007;40:169-70. (Pubitemid 47434877)
14. Barnas ME, Hussain N, Petrides G. Treatment-emergent psychosis with aripiprazole. J Clin Psychiatry 2005;66:1339.
15. Brieger P. Hypomanic episodes after receiving ziprasidone: an unintended "on-off-on" course of treatment. J Clin Psychiatry 2004;65:132-5.
16. Ducroix C, Beghelli F, Rousset I, Vacheron MN. Emergent mania with atypical antipsychotics: review of the literature about one case. Thérapie 2008;63:153-4.
17. Erberk-Ozen N. Manic symptoms probably associated with short-term low-dose quetiapine use. Adv Ther 2008;25:53-8.
18. Keating AM, Aoun SL, Dean CE. Ziprasidone-associated mania: a review and report of 2 additional cases. Clin Neu-ropharmacol 2005;28:83-6. (Pubitemid 40471882)
19. Liang CC, Chen JY, Chen TT, Bai YM. Zotepine-induced mania: two cases report. Eur Neuropsychopharmacol 2006;16(Suppl 4):S419-S.
20. Mishra A, Moore PB, Hobbs R. Does quetiapine have mood altering properties? J Psychopharmacol 2004;18(2):281-4. (Pubitemid 38954918)
21. Padala PR, Wengel SP, Petty F. Manic episode during treatment with aripiprazole. Am J Psychiatry 2007;164:172-3.
22. Park YM, Lee SH, Lee HJ, Kim H, Lee KJ, Kang SG. Ziprasidone-associated mania in Korean schizophrenic patient. J Clin Psychopharmacol 2008;28:711-3.
23. Traber R, Schneiter R, Modestin J. A case of aripiprazole-induced mania. Pharmacopsychiatry 2007;40:37-8. (Pubitemid 46568359)
24. Wang WT, Chen CH, Lu M-L, Lai T-J. Paliperidone-induced mania-like symptoms: A case report. Progress Neuro-Psychopharmacol Biol Psychiatry 2010;34:1351-2.
25. Yokoshima T, Takei N, Tani K, Kawai M, Minabe Y, Mori N. Two cases of perospirone-induced mania in schizophrenia. J Clin Psychiatry 2004;65:135.
26. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder. 2nd ed. Washington, DC:. American Psychiatric Association; 2002 (DOI 101176/appibooks978089042336350051).
27. Malhi GS, Adams D. Are guidelines in need of CPR? The development of clinical practice recommendations (CPR). Acta Psychiatr Scand 2009;Suppl 439:5-7.
28. Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Möller HJ, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on the Treatment of Acute Mania. World J Biol Psychiatry 2009; 10:85-116.
29. Yatham L. E.04.04 CANMAT/ISBD collaborative update of guidelines for bipolar disorder. Eur Neuropsychopharmacol 2009;19(Suppl 3):S222-S.
30. Tatsumi M, Jansen K, Blakely RD, Richelson E. Pharmacological profile of neuroleptics at human monoamine transporters. Eur J Pharmacol 1999;368(2-3):277-83. (Pubitemid 29117150)
31. Nemeroff CB, Lieberman JA, Weiden PJ, Harvey PD, Newcomer JW, Schatzberg AF, et al. From clinical research to clinical practice: a 4-year review of ziprasidone. CNS Spectr 2005;10(11 Suppl 17):1-20.
32. Vis PM, van Baardewijk M, Einarson TR. Duloxetine and venlafaxine-XR in the treatment of major depressive disorder: a meta-analysis of randomized clinical trials. Ann Phar-macother 2005;39(11):1798-807. (Pubitemid 41527690)
33. Angst J. Switch from depression to mania-a record survey over decades between 1920 and 1982. Psychopathology 1985;18:140-54. (Pubitemid 16224274)
34. Ghaemi SN, Hsu DJ, Soldani F, Goodwin FK. Antidepres-sants in bipolar disorder: the case for caution. Bipolar Disord 2003;5:421-33. (Pubitemid 38072244)
35. Mundo E, Cattaneo E, Russo M, Altamura AC. Clinical variables related to antidepressant-induced mania in bipolar disorder. J Affect Disord 2006;92:227-30. (Pubitemid 44269309)
36. Meltzer HY, Matsurbara S, Lee JC. The ratios of serot-onin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugs. Psychopharmacol Bull 1989; 25:390-2. (Pubitemid 20260244)
37. Celada P, Puig MV, Amargós-Bosch M, Adell A, Artigas F. The therapeutic role of 5-HT1A and 5-HT2A receptors in depression. J Psychiatry Neurosci 2004;29:252-65. (Pubitemid 39185866)
38. Carlson T, Reynolds CA, Caplan R. Case report: valproic acid and risperidone treatment leading to development of hyperammonemia and mania. J Am Acad Child Adolesc Psychiatry 2007;46:356-61.
39. Thone J. Worsened agitation and confusion in schizophrenia subsequent to high-dose aripiprazole. J Neuropsychiatry Clin Neurosci 2007;19:481-2. (Pubitemid 350156120)
40. Reeves RR, Mack JE. Worsening schizoaffective disorder with aripiprazole. Am J Psychiatry 2004;161:1308.